SCL Therapeutics Private Limited
About SCL Therapeutics Private Limited
Data last updated:
SCL Therapeutics Private Limited is a private limited company based in Faridabad, Haryana, India. It operates in the other human health activities segment of the healthcare sector. It was incorporated on 09 January 2023.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U85194HR2023PTC109062.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sabita Kumari and Ram Chandra Soni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Accord Hospital Village Budhena Sector – 86 Near Adore Society, Faridabad, Haryana, India – 121002.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.08 Cr, a growth of 109% compared to the previous year. For the same year it recorded a net loss of ₹2.95 Lakh (net margin -0.2%) and EBITDA of ₹6.74 Lakh (EBITDA margin 0.4%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
SCL Therapeutics Private Limited's registered office is in Faridabad, Haryana.
- Registered AddressC/O Accord Hospital Village Budhena Sector – 86 Near Adore Society, Faridabad, Haryana, India – 121002
- IndustryHealthcare, Other Human Health Activities, Physiotherapists, Para Medical, Human Health Activities, Nurses
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of SCL Therapeutics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of SCL Therapeutics Private Limited, buy the company report.
Financials of SCL Therapeutics Private Limited
FY 2025 filings availableSCL Therapeutics Private Limited reported revenue of ₹18.08 Cr (up 109% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 109% in the latest year. EBITDA rose 206% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹6.74 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹2.95 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.4% | ||
| Net Profit Margin | -0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of SCL Therapeutics Private Limited, buy the company report.
Board of directors of SCL Therapeutics Private Limited
SCL Therapeutics has 6 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sabita Kumari | Director | 09 Jan 2023 | 3 Years 9 Months | Current |
| Ram Chandra Soni Also directs: SCL Healthcare Private Limited | Director | 09 Jan 2023 | 3 Years 9 Months | Current |
| Rohit Gupta Also directs: SCL Healthcare Private Limited | Director | 09 Jan 2023 | 3 Years 9 Months | Current |
| Rishi Kumar Gupta Also directs: SCL Healthcare Private Limited, Cardiovascular Foundation | Director | 09 Jan 2023 | 3 Years 9 Months | Current |
| Jitendra Kumar Also directs: Docfusion AI Private Limited, SCL Healthcare Private Limited | Director | 09 Jan 2023 | 3 Years 9 Months | Current |
| Prabal Roy Also directs: SCL Healthcare Private Limited, Medisync AI Private Limited | Director | 09 Jan 2023 | 3 Years 9 Months | Current |
Peer comparison
SCL Therapeutics Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Continua Kids Private Limited | ₹18.17 Cr (FY 2025) | 47.0% | Gurgaon, Haryana, India | |||
| SCL Therapeutics Private Limitedthis company | ₹18.08 Cr (FY 2025) | -₹2.95 Lakh | -0.2% | 109.0% | Faridabad, Haryana, India | |
| Callmedilife Healthcare Services Private Limited | ₹18.04 Cr (FY 2024) | 72.0% | Mumbai, Maharashtra, India | |||
| Kapil Eye Hospital Private Limited | ₹18 Cr (FY 2025) | 11.0% | Ambala, Haryana, India |
To see the full peer comparison of SCL Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving SCL Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for SCL Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for SCL Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
SCL Therapeutics Private Limited has 6 board changes on record since 2023: 6 appointments. The latest: Jitendra Kumar was appointed as Director on 09 Jan 2023.
Frequently asked questions
SCL Therapeutics is an active private limited company based in Faridabad, Haryana, India. The company works in other human health activities, within the healthcare industry. It was incorporated on 09 January 2023 (3+ years old) and is registered under CIN U85194HR2023PTC109062.
SCL Therapeutics has 6 current directors:
- Sabita Kumari - Director
- Ram Chandra Soni - Director
- Rohit Gupta - Director
- Rishi Kumar Gupta - Director
- Jitendra Kumar - Director
- Prabal Roy - Director
The latest financial statements of SCL Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of SCL Therapeutics is U85194HR2023PTC109062. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SCL Therapeutics was incorporated on 09 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of SCL Therapeutics by revenue are Continua Kids Private Limited, Callmedilife Healthcare Services Private Limited, Kapil Eye Hospital Private Limited, all in the Healthcare industry (Preventive Healthcare Services), with the same principal business activity (other hospital and medical care activities).
Jitendra Kumar was appointed as Director on 09 Jan 2023. Prabal Roy was appointed as Director on 09 Jan 2023. Ram Chandra Soni was appointed as Director on 09 Jan 2023. SCL Therapeutics has 6 board changes on record in total.
The registered office of SCL Therapeutics is at CO Accord Hospital Village Budhena Sector – 86 Near Adore Society, Faridabad, Haryana, India – 121002.
SCL Therapeutics operates in the healthcare industry, in the other human health activities segment.
The compliance status of SCL Therapeutics is compliant as of 02 August 2026. The company is actively filing with the Registrar of Companies.
SCL Therapeutics can be reached at its registered office: CO Accord Hospital Village Budhena Sector – 86 Near Adore Society, Faridabad, Haryana, India – 121002.